Abstract

RABELLINO, MARTÍN et al. Clinical Outcome of Drug-Eluting Balloon Endovascular Treatment for Femoropopliteal Lesions in Patients with Intermittent Claudication. Rev. argent. cardiol. [online]. 2018, vol.86, n.4, pp.43-52. ISSN 1850-3748.

Background: Restenosis continues to be the great challenge of endovascular therapy, and drug-eluting balloons (DEB) have been developed to reduce it. The aim of this study was to analyze the results of this therapy.

Methods: A retrospective analysis of 40 limbs with femoropopliteal lesions treated with DEB was conducted in patients with intermittent claudication.

Results: Technical success was obtained in the 40 (100%) limbs treated, without evidence of serious complications related with treatment, and with 92.5% of asymptomatic limbs during the follow-up period of 11.1 months. In three limbs, a new angioplasty was performed due to symptomatic recurrence.

Conclusions: The drug-eluting balloon has proven to be a useful, safe and effective tool for the treatment of de novo and in-stent restenosis lesions; however, TASC C-D lesions require the use of greater number of stents.

Keywords : Neointima - Hyperplasia - Drug-Eluting Ballons - Intermittent Claudication - Femoral Artery - Popliteal.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )